Biliary Sclerosis after Hepatic Arterial Infusion Pump Chemotherapy for Patients with Colorectal Cancer Liver Metastasis: Incidence, Clinical Features, and Risk Factors

[1]  T. Eberlein.  Conversion to Resectability Using Hepatic Artery Infusion Plus Systemic Chemotherapy for the Treatment of Unresectable Liver Metastases From Colorectal Carcinoma , 2011 .

[2]  C. Ng,et al.  A phase 1 study of hepatic arterial infusion of oxaliplatin in combination with systemic 5‐fluorouracil, leucovorin, and bevacizumab in patients with advanced solid tumors metastatic to the liver , 2010, Cancer.

[3]  T. de Baère,et al.  Prolonged Survival of Initially Unresectable Hepatic Colorectal Cancer Patients Treated With Hepatic Arterial Infusion of Oxaliplatin Followed by Radical Surgery of Metastases , 2010, Annals of surgery.

[4]  F. Lévi,et al.  Rescue chemotherapy using multidrug chronomodulated hepatic arterial infusion for patients with heavily pretreated metastatic colorectal cancer , 2009, Cancer.

[5]  M. D'Angelica,et al.  Phase I trial of adjuvant hepatic arterial infusion (HAI) with floxuridine (FUDR) and dexamethasone plus systemic oxaliplatin, 5-fluorouracil and leucovorin in patients with resected liver metastases from colorectal cancer. , 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

[6]  P. Hahn,et al.  Thirty years' experience with balloon dilation of benign postoperative biliary strictures: long-term outcomes. , 2008, Radiology.

[7]  M. Ducreux,et al.  Hepatic Arterial Infusion of Oxaliplatin and Intravenous LV5FU2 in Unresectable Liver Metastases from Colorectal Cancer after Systemic Chemotherapy Failure , 2007, Annals of Surgical Oncology.

[8]  N. Kemeny,et al.  Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: a randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481). , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  Agnès Laplanche,et al.  Hepatic arterial oxaliplatin infusion plus intravenous chemotherapy in colorectal cancer with inoperable hepatic metastases: a trial of the gastrointestinal group of the Federation Nationale des Centres de Lutte Contre le Cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  L. Schwartz,et al.  Hepatic arterial infusion of floxuridine and dexamethasone plus high‐dose Mitomycin C for patients with unresectable hepatic metastases from colorectal carcinoma , 2005, Journal of surgical oncology.

[11]  L. Schwartz,et al.  Phase I trial of systemic oxaliplatin combination chemotherapy with hepatic arterial infusion in patients with unresectable liver metastases from colorectal cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  L. Ben-Porat,et al.  Technical complications and durability of hepatic artery infusion pumps for unresectable colorectal liver metastases: an institutional experience of 544 consecutive cases. , 2005, Journal of the American College of Surgeons.

[13]  Robert C. G. Martin,et al.  Morbidity of adjuvant hepatic arterial infusion pump chemotherapy in the management of colorectal cancer metastatic to the liver. , 2004, American journal of surgery.

[14]  G. Costamagna,et al.  Current management of postoperative complications and benign biliary strictures. , 2003, Gastrointestinal endoscopy clinics of North America.

[15]  M. Gonen,et al.  Phase I/II study of hepatic arterial therapy with floxuridine and dexamethasone in combination with intravenous irinotecan as adjuvant treatment after resection of hepatic metastases from colorectal cancer. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  S. Lipsitz,et al.  Abstracts reprinted from Journal of Clinical Oncology , 2002, Annals of Surgical Oncology.

[17]  N. Kemeny,et al.  Hepatic-arterial chemotherapy. , 2001, The Lancet. Oncology.

[18]  L. Schwartz,et al.  Phase I study of hepatic arterial infusion of floxuridine and dexamethasone with systemic irinotecan for unresectable hepatic metastases from colorectal cancer. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  M. Lorenz,et al.  Randomized, multicenter trial of fluorouracil plus leucovorin administered either via hepatic arterial or intravenous infusion versus fluorodeoxyuridine administered via hepatic arterial infusion in patients with nonresectable liver metastases from colorectal carcinoma. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  L H Blumgart,et al.  Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. , 1999, The New England journal of medicine.

[21]  L H Blumgart,et al.  Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. , 1999, Annals of surgery.

[22]  K. Lillemoe.  Benign post-operative bile duct strictures. , 1997, Bailliere's clinical gastroenterology.

[23]  David J. Kim,et al.  Primary sclerosing cholangitis , 2001, The New England journal of medicine.

[24]  N. Kemeny,et al.  Phase II study of hepatic arterial floxuridine, leucovorin, and dexamethasone for unresectable liver metastases from colorectal carcinoma. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  N. Kemeny,et al.  Hepatic arterial floxuridine and leucovorin for unresectable liver metastases from colorectal carcinoma. New dose schedules and survival update , 1994, Cancer.

[26]  N. Kemeny,et al.  A pilot study of hepatic artery floxuridine combined with systemic 5‐fluorouracil and leucovorin. A potential adjuvant program after resection of colorectal hepatic metastases , 1993, Cancer.

[27]  P. Rougier,et al.  Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long-term results of a prospective randomized trial. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  J. K. Martin,et al.  Intra-arterial floxuridine vs systemic fluorouracil for hepatic metastases from colorectal cancer. A randomized trial. , 1990, Archives of surgery.

[29]  J. Hannigan,et al.  A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: the Northern California Oncology Group trial. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  R. Wiesner,et al.  Floxuridine‐induced sclerosing cholangitis: An ischemic cholangiopathy? , 1989, Hepatology.

[31]  P D Schneider,et al.  A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases. , 1987, Annals of surgery.

[32]  N. Geller,et al.  Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. A randomized trial. , 1987, Annals of internal medicine.

[33]  M. Kemeny,et al.  Sclerosing Cholangitis after Continuous Hepatic Artery Infusiori of FUDR , 1985, Annals of surgery.

[34]  N. Kemeny,et al.  Long-term hepatic arterial infusion chemotherapy. Anatomic considerations, operative technique, and treatment morbidity. , 1984, Archives of surgery.

[35]  N. Michels,et al.  Newer anatomy of the liver and its variant blood supply and collateral circulation. , 1966, American journal of surgery.